Wikisage, the free encyclopedia of the second generation, is digital heritage
Sjögren syndrome: Difference between revisions
Jump to navigation
Jump to search
m (hide) |
mNo edit summary |
||
| Line 2: | Line 2: | ||
The eponymous Sjögren syndrome is a keratoconjuntivitis sicca xerosftalmia<ref>dictionary of medical eponyms Ediciones Roche Basle, Switzerland, p 495</ref> | The eponymous Sjögren syndrome is a keratoconjuntivitis sicca xerosftalmia<ref>dictionary of medical eponyms Ediciones Roche Basle, Switzerland, p 495</ref> | ||
It is a chronic and progressive multisystem autoimmune disease typically managed by rheumatologists | It is a chronic and progressive multisystem autoimmune disease typically managed by rheumatologists, <ref>[https://www.ncbi.nlm.nih.gov/pubmed/28283891 The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis]</ref> | ||
affecting 0.3 - 5 % of the general population | |||
<ref>Fox RI. Sjögren’s syndrome. Lancet. 2005;366: 321–31</ref> | |||
==Links== | ==Links== | ||
[http://www.tandfonline.com/doi/abs/10.1080/08916934.2017.1280027?journalCode=iaut20 Inflammation in Sjögren's syndrome: Cause or consequence?] | [http://www.tandfonline.com/doi/abs/10.1080/08916934.2017.1280027?journalCode=iaut20 Inflammation in Sjögren's syndrome: Cause or consequence?] | ||
Revision as of 13:47, 12 March 2017
-
Karcher/PP(c)
The eponymous Sjögren syndrome is a keratoconjuntivitis sicca xerosftalmia[1] It is a chronic and progressive multisystem autoimmune disease typically managed by rheumatologists, [2] affecting 0.3 - 5 % of the general population [3]
Links
Inflammation in Sjögren's syndrome: Cause or consequence?
- ↑ dictionary of medical eponyms Ediciones Roche Basle, Switzerland, p 495
- ↑ The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis
- ↑ Fox RI. Sjögren’s syndrome. Lancet. 2005;366: 321–31